Obesity is a chronic disease that can be treated with comprehensive and lifelong care, so people should not expect a one-time treatment through medication, the Taiwan Medical Association for the Study of Obesity said yesterday, as it released the 2025 Clinical Practice Guidelines on Adult Obesity in Taiwan.
The clinical practice guidelines were announced at the 25th annual congress of the association in conjunction with the 9th Japan-Korea-Taiwan Symposium on Obesity at National Taiwan University Hospital’s International Convention Center in Taipei.
The association said the new guidelines align with the WHO’s latest fact sheet on obesity and its global guidelines on the use of glucagon-like peptide-1 (GLP-1) therapies in treating obesity, issued earlier this month.
Photo: CNA
Association president Lin Wen-yuan (林文元) said the WHO’s new guidelines recognize that obesity is “a chronic disease that can be treated with comprehensive and lifelong care,” and that GLP-1 therapies might be used by adults for the long-term treatment of obesity, adding that it also stressed that medication alone could not reverse the serious health challenge.
The WHO classifies obesity as “a chronic, relapsing disease arising from complex interactions between genetics, neurobiology, eating behaviors, access to healthy diet, market forces and the broader environment.”
GLP-1 therapies could support people in overcoming obesity, as “a part of a comprehensive approach that includes healthy diets, regular physical activity and support from health professionals,” the WHO says.
Lin said the 2025 Clinical Practice Guidelines on Adult Obesity in Taiwan redefined obesity — not only looking at a person’s body mass index (BMI), but also their waist circumference, body composition and metabolic risks — allowing the diagnosis to be more refined.
The guidelines also added more diversity to the recommended treatment of obesity, including lifestyle adjustments, nutrition intake and regular physical activity plans, mental support, medications (including GLP-1 therapies), endoscopic bariatric therapy, and bariatric surgery, he said.
Moreover, the guidelines provide more customized care recommendations for different groups of people with obesity, including elderly people, pregnant women or women going through menopause, he said.
They also emphasize patient-centric treatment with empathetic communication, while refusing stigmatization, he said.
The WHO defines obesity as having a BMI of 30 or higher in adults, and Taiwan’s guidelines define it as a BMI of 27 or higher.
Association secretary-general Kao Hsiang-han (高湘涵) said according to the new guidelines, people with a BMI of 27 or higher, along with at least one comorbidity, are eligible for GLP-1 therapy, while people with a BMI of 24 to 27 are overweight, meaning that they are advised to first receive lifestyle intervention for several months before considering the use of GLP-1 therapies.
However, Lin said the association has also observed abusive use of GLP-1 therapies, such as being used by people who are not obese or excessive use, which could cause health risks including substantial muscle loss.
People should only receive GLP-1 therapies prescribed and monitored by health professionals, he added.
Additional reporting by CNA
PROVOCATIVE: Chinese Deputy Ambassador to the UN Sun Lei accused Japan of sending military vessels to deliberately provoke tensions in the Taiwan Strait China denounced remarks by Japan and the EU about the South China Sea at a UN Security Council meeting on Monday, and accused Tokyo of provocative behavior in the Taiwan Strait and planning military expansion. Ayano Kunimitsu, a Japanese vice foreign minister, told the Council meeting on maritime security that Tokyo was seriously concerned about the situation in the East China and South China seas, and reiterated Japan’s opposition to any attempt to change the “status quo” by force, and obstruction of freedom of navigation and overflight. Stavros Lambrinidis, head of the EU delegation to the UN, also highlighted South China Sea
The final batch of 28 M1A2T Abrams tanks purchased from the US arrived at Taipei Port last night and were transported to the Armor Training Command in Hsinchu County’s Hukou Township (湖口), completing the military’s multi-year procurement of 108 of the tanks. Starting at 12:10am today, reporters observed more than a dozen civilian flatbed trailers departing from Taipei Port, each carrying an M1A2T tank covered with black waterproof tarps. Escorted by military vehicles, the convoy traveled via the West Coast Expressway to the Armor Training Command, with police implementing traffic control. The army operates about 1,000 tanks, including CM-11 Brave Tiger
China on Wednesday teased in a video an aircraft carrier that could be its fourth, and the first using nuclear power, while making an allusion to Taiwan and vowing to further build up its islands, as it looks to boost maritime power, secure resources and bolster territorial claims. The video, issued on the eve of the 77th founding anniversary of the Chinese People’s Liberation Army Navy, featured fictional officers with names that are homophones of three commissioned aircraft carriers, the Liaoning (遼寧), Shandong (山東) and Fujian (福建). Titled Into the Deep, it showed a 19-year-old named “Hejian” (何劍) joining the group, sparking
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, said it expects its 2-nanometer (2nm) chip capacity to grow at a compound annual rate of 70 percent from this year to 2028. The projection comes as five fabs begin volume production of 2-nanometer chips this year — two in Hsinchu and three in Kaohsiung — TSMC senior vice president and deputy cochief operating officer Cliff Hou (侯永清) said at the company’s annual technology symposium in Silicon Valley, California, last week. Output in the first year of 2-nanometer production, which began in the fourth quarter of last year, is expected to
RSS